A groundbreaking trial at Mass General Brigham uses reprogrammed stem cells from patients to replace damaged dopamine neurons in Parkinson's disease. Could this lead to a new treatment paradigm?
A groundbreaking trial at Mass General Brigham uses reprogrammed stem cells from patients to replace damaged dopamine neurons in Parkinson's disease. Could this lead to a new treatment paradigm?